
Roche Holding AG
SIX:ROG

Roche Holding AG?
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
Banking
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
Technology
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
US |
![]() |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
US |
![]() |
Visa Inc
NYSE:V
|
Technology
|
CN |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
US |
![]() |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
Beverages
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
Retail
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
We'll email you a reminder when the closing price reaches USD.
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.

Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
214.1
311.1
|
Price Target |
|
We'll email you a reminder when the closing price reaches CHF.
Choose the stock you wish to monitor with a price alert.
![]() |
Johnson & Johnson
NYSE:JNJ
|
US |
![]() |
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
![]() |
Bank of America Corp
NYSE:BAC
|
US |
![]() |
Mastercard Inc
NYSE:MA
|
US |
![]() |
UnitedHealth Group Inc
NYSE:UNH
|
US |
![]() |
Exxon Mobil Corp
NYSE:XOM
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
US |
![]() |
Palantir Technologies Inc
NYSE:PLTR
|
US |
![]() |
Nike Inc
NYSE:NKE
|
US |
![]() |
Visa Inc
NYSE:V
|
US |
![]() |
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
![]() |
3M Co
NYSE:MMM
|
US |
![]() |
JPMorgan Chase & Co
NYSE:JPM
|
US |
![]() |
Coca-Cola Co
NYSE:KO
|
US |
![]() |
Walmart Inc
NYSE:WMT
|
US |
![]() |
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.

What unique competitive advantages
does Roche Holding AG hold over its rivals?
What risks and challenges
does Roche Holding AG face in the near future?
Is it considered overvalued or undervalued
based on the latest financial data?
Provide an overview of the primary business activities
of Roche Holding AG.
Provide an overview of the primary business activities
of Roche Holding AG.
What unique competitive advantages
does Roche Holding AG hold over its rivals?
What risks and challenges
does Roche Holding AG face in the near future?
Has there been any significant insider trading activity
in Roche Holding AG recently?
Summarize the latest earnings call
of Roche Holding AG.
What significant events have occurred
in Roche Holding AG over the past months?
Is it considered overvalued or undervalued
based on the latest financial data?
Show all valuation multiples
for Roche Holding AG.
Provide P/S
for Roche Holding AG.
Provide P/E
for Roche Holding AG.
Provide P/OCF
for Roche Holding AG.
Provide P/FCFE
for Roche Holding AG.
Provide P/B
for Roche Holding AG.
Provide EV/S
for Roche Holding AG.
Provide EV/GP
for Roche Holding AG.
Provide EV/EBITDA
for Roche Holding AG.
Provide EV/EBIT
for Roche Holding AG.
Provide EV/OCF
for Roche Holding AG.
Provide EV/FCFF
for Roche Holding AG.
Provide EV/IC
for Roche Holding AG.
Show me price targets
for Roche Holding AG made by professional analysts.
What are the Revenue projections
for Roche Holding AG?
How accurate were the past Revenue estimates
for Roche Holding AG?
What are the Net Income projections
for Roche Holding AG?
How accurate were the past Net Income estimates
for Roche Holding AG?
What are the EPS projections
for Roche Holding AG?
How accurate were the past EPS estimates
for Roche Holding AG?
What are the EBIT projections
for Roche Holding AG?
How accurate were the past EBIT estimates
for Roche Holding AG?
Compare the revenue forecasts
for Roche Holding AG with those of its competitors based on recent analyst estimates.
Compare the intrinsic valuations
of Roche Holding AG and its key competitors using the latest financial data.
Compare historical revenue growth rates
of Roche Holding AG against its competitors.
Analyze the profit margins
(gross, operating, and net) of Roche Holding AG compared to its peers.
Compare the P/E ratios
of Roche Holding AG against its peers.
Discuss the investment returns and shareholder value creation
comparing Roche Holding AG with its peers.
Analyze the financial leverage
of Roche Holding AG compared to its main competitors.
Show all profitability ratios
for Roche Holding AG.
Provide ROE
for Roche Holding AG.
Provide ROA
for Roche Holding AG.
Provide ROIC
for Roche Holding AG.
Provide ROCE
for Roche Holding AG.
Provide Gross Margin
for Roche Holding AG.
Provide Operating Margin
for Roche Holding AG.
Provide Net Margin
for Roche Holding AG.
Provide FCF Margin
for Roche Holding AG.
Show all solvency ratios
for Roche Holding AG.
Provide D/E Ratio
for Roche Holding AG.
Provide D/A Ratio
for Roche Holding AG.
Provide Interest Coverage Ratio
for Roche Holding AG.
Provide Altman Z-Score Ratio
for Roche Holding AG.
Provide Quick Ratio
for Roche Holding AG.
Provide Current Ratio
for Roche Holding AG.
Provide Cash Ratio
for Roche Holding AG.
What is the historical Revenue growth
over the last 5 years for Roche Holding AG?
What is the historical Net Income growth
over the last 5 years for Roche Holding AG?
What is the current Free Cash Flow
of Roche Holding AG?
Discuss the annual earnings per share (EPS)
trend over the past five years for Roche Holding AG.
EV/EBITDA
Enterprise Value to EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s cash earnings less non-cash expenses. EBITDA can be misleading at times, especially for companies that are highly capital intensive.
Market Cap | EV/EBITDA | ||||
---|---|---|---|---|---|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
222B CHF | 10.8 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
747.7B USD | 41.1 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
440.4B GBP | 3 846.3 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
384.7B USD | 12.8 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
2T DKK | 13.2 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
176.6B GBP | 127 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
197B CHF | 11.4 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
218.7B USD | 8.6 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
167.6B USD | 267.5 |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
137.6B USD | 8.3 |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
124.4B EUR | 9.4 |
|
EBITDA Growth | EV/EBITDA to Growth | |||||
---|---|---|---|---|---|---|
CH |
![]() |
Roche Holding AG
SIX:ROG
|
Average EV/EBITDA:
396
10.8
|
8%
|
1.4 | |
US |
![]() |
Eli Lilly and Co
NYSE:LLY
|
41.1
|
30%
|
1.4 |
|
UK |
![]() |
Dechra Pharmaceuticals PLC
LSE:DPH
|
3 846.3
|
36%
|
106.8 |
|
US |
![]() |
Johnson & Johnson
NYSE:JNJ
|
12.8
|
7%
|
1.8 |
|
DK |
![]() |
Novo Nordisk A/S
CSE:NOVO B
|
13.2
|
15%
|
0.9 |
|
UK |
![]() |
AstraZeneca PLC
LSE:AZN
|
127
|
9%
|
14.1 |
|
CH |
![]() |
Novartis AG
SIX:NOVN
|
11.4
|
5%
|
2.3 |
|
US |
![]() |
Merck & Co Inc
NYSE:MRK
|
8.6
|
9%
|
1 |
|
IE |
E
|
Endo International PLC
LSE:0Y5F
|
267.5
|
N/A | N/A |
|
US |
![]() |
Pfizer Inc
NYSE:PFE
|
8.3
|
3%
|
2.8 |
|
FR |
![]() |
Sanofi SA
PAR:SAN
|
9.4
|
7%
|
1.3 |
|
EV/EBITDA Forward Multiples
Forward EV/EBITDA multiple is a version of the EV/EBITDA ratio that uses forecasted EBITDA for the EV/EBITDA calculation. 1-Year, 2-Years, and 3-Years forwards use EBITDA forecasts for 1, 2, and 3 years ahead, respectively.